{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:17:00Z","timestamp":1788283020507,"version":"build-2803163510"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajo.2026.05.050","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:22:20Z","timestamp":1782490940000},"page":"376-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comment on: Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-1690","authenticated-orcid":false,"given":"BIJNYA BIRAJITA","family":"PANDA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.ajo.2026.05.050_bib0001","first-page":"00179","article-title":"Clinicopathological and imaging distinction between ocular adnexal MALT lymphoma and IgG4-related ophthalmic disease","volume":"S0002-9394","author":"Hao","year":"2026","journal-title":"Am J Ophthalmol."},{"issue":"1","key":"10.1016\/j.ajo.2026.05.050_bib0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"Members of the ACR\/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology\/European League against Rheumatism Classification Criteria for IgG4-related Disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.050_bib0003","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis."},{"issue":"8","key":"10.1016\/j.ajo.2026.05.050_bib0004","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1755-3768.2012.02526.x","article-title":"IgG4-related orbital disease: a meta-analysis and review","volume":"91","author":"Andrew","year":"2013","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"10.1016\/j.ajo.2026.05.050_bib0005","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/cancers14051264","article-title":"The biology of ocular adnexal marginal zone lymphomas","volume":"14","author":"Johansson","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"3","key":"10.1016\/j.ajo.2026.05.050_bib0006","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/1319-4534.343368","article-title":"Ocular adnexal lymphoma: a single-institution retrospective study","volume":"35","author":"Fern\u00e1ndez","year":"2021","journal-title":"Saudi J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426003533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:33:38Z","timestamp":1788280418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426003533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":6,"alternative-id":["S0002939426003533"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.050","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on: Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.04.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}